Latest Content

A secret shopper study finds most are still compounding semaglutide and tirzepatide with additives, often through suppliers lacking sterile compounding licenses.

Richard Dion, PharmD, joins to discuss the growing prominence of opioid stewardship and where the pharmacist can assist in patient programming.

Analyzing nearly a decade of pharmaceutical interventions in community pharmacies, researchers reveal the role pharmacists play in self-medication.

Bivalent mRNA and protein-based fourth doses produce comparable protection against Omicron JN.1 infection over 12 months.

In part 1 of our interview with Paul Licciardi, PhD, he addresses the lowered pneumococcal vaccination age as well as the adult population’s overall relationship with immunization.

Pharmacist credentialing unlocks payer contracts and boosts reimbursement and can help avoid risky third-party billing as clinical services expand.

With calls to expand access across the health care ecosystem, researchers explore pharmacists' perceptions regarding independent prescribing.

A rapidly growing multistate cyclosporiasis outbreak has pushed national case counts to nearly 7000.

With the Medicare GLP-1 Bridge Program just 2 weeks old, a drug market expert shared their thoughts on what the initiative may mean for pharmacists and their patients.

Among adult patients who have reported a case of invasive pneumococcal disease, researchers address the association of risk factors and recurrent disease.

Lipfendra (enlicitide) showed placebo-adjusted low-density lipoprotein cholesterol reductions of more than 50% in 2 phase 3 trials.

Emerging data show glucagon-like peptide-1 receptor agonists may raise the risk of certain autoimmune diseases compared with other diabetes drugs.

In this episode, Natalie DiPietro Mager, PharmD, PhD, talks with Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, about how pharmacists can address cannabis use in women during adolescence, reproductive years, and older adulthood.

Investigators test 3 repurposed drugs alongside specialist care, finding small, transient fatigue improvements for long COVID fatigue.

With GLP-1 questions creating confusion for Medicare patients, pharmacists are becoming the trusted frontline resource, and the stakes for getting it right have never been higher.

New research links a national surge in poison control calls involving semaglutide to preventable dosing mistakes rather than intentional misuse.

With the goal of optimizing long-term weight-loss treatment, researchers gather insights regarding the lived experiences of glucagon-like peptide-1 users.

Drug shortages drop in 2025, yet long-lasting sterile injectable gaps, rising discontinuations, and fragile supply chains reshape pharmacy work.

In an assessment of pharmacy closures, researchers hypothesize underserved neighborhoods would be the most burdened locations across the country.

Subcutaneous lecanemab-irmb can now be self-administered or given by a caregiver from the first dose, eliminating the requirement for an initial in-clinic intravenous infusion.

This episode meanders the time of the year where pharmacy professionals experience a lull in business, providing them with the perfect opportunity to invest in growth.

Jay Bregman, founder and CEO of Andel, discusses the current GLP-1 landscape and how a new Medicare initiative is designed to improve access to this increasingly popular medication class.

A new analysis shows that socioeconomic status shrinks type 2 diabetes risk far more for nonHispanic white and Asian Americans than for nonHispanic Black and Hispanic Americans.

Researchers assess how these emerging platforms can support medication use across this patient population.

A newly published review traces chikungunya's re-emergence to a record 2025 outbreak in China, and 2 FDA-approved vaccines shape prevention strategy for pharmacists.

Within the arena of chronic nonmalignant pain, researchers explore barriers, facilitators, and strategies for opioid optimization services in community pharmacies.

Diyaben Patel, PharmD, discusses where artificial intelligence is genuinely transforming pharmacy practice.

Exploring retail pharmacy data, specifically among Walgreens locations, researchers assess the impact of closures in socially vulnerable areas.

Price transparency, direct-to-consumer, and digital fulfillment channels are reshaping how patients obtain medications.

Often operating in the shadows, LTC pharmacy is the backbone of medication management for aging and immunocompromised patients.

New case-control study finds that patients with type 2 diabetes and more severe depressive symptoms show higher cortisol, higher hemoglobin A1C, and lower insulin.